Estrogen (E), acting through the estrogen receptor (ER), plays a critical role in gene expression in target tissues such as breast, bone, and the pituitary, where it controls hormone production and cell proliferation. Cell-specific responses to E are well-documented, and mechanisms include differential expression of ER isoforms, distinct pathways of ligand- independent ER stimulation, and differential expression of ER coactivator and repressor proteins. We previously identified a pituitary-specific truncated ERalpha in rat pituitary cells (TERP). TERP is transcribed from a unique promoter and dramatically regulated by E, divergent from full-length ER, such that the TERP:ER ratio varies from 0:1 to 3-4:1. We cloned the intronic TERP promoter for the rat and mouse ERalpha genes, and found it is stimulated by E in transfection assays. TERP cannot bind DNA, but modulates ER transcriptional activity biphasic manner, dependent on TERP:ER ratios. When TERP:ER ratios are high (greater than 1:1) ER activity is suppressed by the formation of TERP:ER heterodimers that cannot bind DNA. At low ratios TERP stimulates ER activity, and we hypothesize this occurs by titration of repressor proteins. One such protein is Repressor of Estrogen Receptor Activity (REA), expressed in pituitary cells, and other repressors may be identified. We will determine the biological role of TERP and its physiological regulation in four specific aims. 1) Interactions of TERP with REA and other ER repressors will be evaluated at the level of protein-protein interactions, the ability of TERP to compete with ER binding to repressors, and to rescue suppressed ER transcription. 2) Expression of the mouse TERP promoter will be analyzed in transient transfection assays for basal enhancer and E-regulated regions. Proteins binding to these sites will be identified, and the ability of TERP to autoregulate its own promoter will be determined. 3) Expression of TERP mRNA during development in male and female mice will be evaluated. 4) Transgenic mice in which TERP expression is eliminated by selective TERP promoter disruption will be produced, and physiological responses of lactotropes and gonadotropes to E will be characterized. Cell-specific ER isoforms with varying biological activities has profound physiological implications for cell function and growth. These studies will provide important information on mechanisms for positive and negative E feedback at the cellular level.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK057082-13
Application #
6544895
Study Section
Endocrinology Study Section (END)
Program Officer
Margolis, Ronald N
Project Start
1989-06-01
Project End
2006-07-31
Budget Start
2002-08-01
Budget End
2003-07-31
Support Year
13
Fiscal Year
2002
Total Cost
$254,304
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Fox, Emily M; Andrade, Josefa; Shupnik, Margaret A (2009) Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 74:622-7
Wen, J; Li, R; Lu, Y et al. (2009) Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions. Oncogene 28:575-86
Fox, Emily M; Bernaciak, Teresa M; Wen, Jie et al. (2008) Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Mol Endocrinol 22:1781-96
Fox, Emily M; Davis, Rebecca J; Shupnik, Margaret A (2008) ERbeta in breast cancer--onlooker, passive player, or active protector? Steroids 73:1039-51
Silva, Corinne M; Shupnik, Margaret A (2007) Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance. Mol Endocrinol 21:1499-512
Bryant, Winnifred M; Gibson, Matthew A; Shupnik, Margaret A (2006) Stimulation of the novel estrogen receptor-alpha intronic TERP-1 promoter by estrogens, androgen, pituitary adenylate cyclase-activating peptide, and forskolin, and autoregulation by TERP-1 protein. Endocrinology 147:543-51
Boerner, Julie L; Gibson, Matthew A; Fox, Emily M et al. (2005) Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells. Mol Endocrinol 19:2660-70
Bryant, Winnifred; Snowhite, Allison E; Rice, Laurel W et al. (2005) The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells. Endocrinology 146:751-9
Tsai, Houng-Wei; Katzenellenbogen, John A; Katzenellenbogen, Benita S et al. (2004) Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation. Endocrinology 145:2730-8
Lin, Vicky Y; Resnick, Eileen M; Shupnik, Margaret A (2003) Truncated estrogen receptor product-1 stimulates estrogen receptor alpha transcriptional activity by titration of repressor proteins. J Biol Chem 278:38125-31

Showing the most recent 10 out of 16 publications